Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
AP2M1 |
adaptor-related protein complex 2, mu 1 subunit, transcript variant 1 |
FXC00018
|
FHC00018
|
FNC00018N
|
FNC00018C
|
GIT2 |
G protein-coupled receptor kinase interacting ArfGAP 2, transcript variant 6 |
FXC00029
|
FHC00029
|
FNC00029N
|
FNC00029C
|
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase, transcript variant c |
FXC00077
|
FHC00077
|
FNC00077N
|
FNC00077C
|
DNAJC6 |
DnaJ (Hsp40) homolog, subfamily C, member 6, transcript variant 2 |
FXC00085
|
FHC00085
|
FNC00085N
|
FNC00085C
|
SPG20 |
spastic paraplegia 20 (Troyer syndrome), transcript variant 1 |
FXC00108
|
FHC00108
|
FNC00108N
|
FNC00108C
|
NEDD4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase, transcript variant 1 |
FXC00406
|
FHC00406
|
FNC00406N
|
FNC00406C
|
AGAP2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2, transcript variant 2 |
FXC00439
|
FHC00439
|
FNC00439N
|
FNC00439C
|
IST1 |
increased sodium tolerance 1 homolog (yeast), transcript variant 1 |
FXC00445
|
FHC00445
|
FNC00445N
|
FNC00445C
|
GBF1 |
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant 1 |
FXC00476
|
FHC00476
|
FNC00476N
|
FNC00476C
|
RNMT |
RNA (guanine-7-) methyltransferase, transcript variant 2 |
FXC00528
|
FHC00528
|
FNC00528N
|
FNC00528C
|
ARAP1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1, transcript variant 1 |
FXC00637
|
FHC00637
|
FNC00637N
|
FNC00637C
|
ZFYVE9 |
zinc finger, FYVE domain containing 9 |
FXC01024
|
FHC01024
|
FNC01024N
|
FNC01024C
|
USP8 |
ubiquitin specific peptidase 8, transcript variant 1 |
FXC01051
|
FHC01051
|
FNC01051N
|
FNC01051C
|
ARAP2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
FXC01096
|
FHC01096
|
FNC01096N
|
FNC01096C
|
KIAA1033 |
KIAA1033, transcript variant 2 |
FXC01144
|
FHC01144
|
FNC01144N
|
FNC01144C
|
EPS15 |
epidermal growth factor receptor pathway substrate 15, transcript variant 1 |
FXC01252
|
FHC01252
|
FNC01252N
|
FNC01252C
|
EHD1 |
EH-domain containing 1, transcript variant 2 |
FXC01294
|
FHC01294
|
FNC01294N
|
FNC01294C
|
RET |
ret proto-oncogene, transcript variant 4 |
FXC01300
|
FHC01300
|
FNC01300N
|
FNC01300C
|
TGFBR1 |
transforming growth factor, beta receptor 1, transcript variant 1 |
FXC01305
|
FHC01305
|
FNC01305N
|
FNC01305C
|
BRD8 |
bromodomain containing 8, transcript variant 1 |
FXC01311
|
FHC01311
|
FNC01311N
|
FNC01311C
|
AP2B1 |
adaptor-related protein complex 2, beta 1 subunit, transcript variant 2 |
FXC01387
|
FHC01387
|
FNC01387N
|
FNC01387C
|
LDLR |
low density lipoprotein receptor, transcript variant 2 |
FXC01394
|
FHC01394
|
FNC01394N
|
FNC01394C
|
PML |
promyelocytic leukemia |
FXC01397
|
FHC01397
|
FNC01397N
|
FNC01397C
|
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa), transcript variant 2 |
FXC01401
|
FHC01401
|
FNC01401N
|
FNC01401C
|
ARF1 |
ADP-ribosylation factor 1, transcript variant 4 |
FXC01517
|
FHC01517
|
FNC01517N
|
FNC01517C
|
RAB7A |
RAB7A, member RAS oncogene family |
FXC01520
|
FHC01520
|
FNC01520N
|
FNC01520C
|
RHOA |
ras homolog family member A |
FXC01522
|
FHC01522
|
FNC01522N
|
FNC01522C
|
EHD2 |
EH-domain containing 2 |
FXC01527
|
FHC01527
|
FNC01527N
|
FNC01527C
|
TRAF6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase, transcript variant 2 |
FXC01545
|
FHC01545
|
FNC01545N
|
FNC01545C
|
IGF1R |
insulin-like growth factor 1 receptor, transcript variant 2 |
FXC01578
|
FHC01578
|
FNC01578N
|
FNC01578C
|
PDCD6IP |
programmed cell death 6 interacting protein, transcript variant 1 |
FXC01687
|
FHC01687
|
FNC01687N
|
FNC01687C
|
TFRC |
transferrin receptor, transcript variant 1 |
FXC01759
|
FHC01759
|
FNC01759N
|
FNC01759C
|
GIT1 |
G protein-coupled receptor kinase interacting ArfGAP 1, transcript variant 1 |
FXC01778
|
FHC01778
|
FNC01778N
|
FNC01778C
|
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, transcript variant 2 |
FXC01839
|
FHC01839
|
FNC01839N
|
FNC01839C
|
FLT1 |
fms-related tyrosine kinase 1, transcript variant 1 |
FXC01847
|
FHC01847
|
FNC01847N
|
FNC01847C
|
KIAA0196 |
KIAA0196 |
FXC01963
|
FHC01963
|
FNC01963N
|
FNC01963C
|
PSD |
pleckstrin and Sec7 domain containing, transcript variant 1 |
FXC02061
|
FHC02061
|
FNC02061N
|
FNC02061C
|
IL2RB |
interleukin 2 receptor, beta |
FXC02076
|
FHC02076
|
FNC02076N
|
FNC02076C
|
ARF6 |
ADP-ribosylation factor 6 |
FXC02124
|
FHC02124
|
FNC02124N
|
FNC02124C
|
SNF8 |
SNF8, ESCRT-II complex subunit |
FXC02507
|
FHC02507
|
FNC02507N
|
FNC02507C
|
CHMP3 |
charged multivesicular body protein 3, transcript variant 1 |
FXC02581
|
FHC02581
|
FNC02581N
|
FNC02581C
|
SPG21 |
spastic paraplegia 21 (autosomal recessive, Mast syndrome), transcript variant 1 |
FXC02600
|
FHC02600
|
FNC02600N
|
FNC02600C
|
CLTA |
clathrin, light chain A, transcript variant 2 |
FXC02674
|
FHC02674
|
FNC02674N
|
FNC02674C
|
RAB5B |
RAB5B, member RAS oncogene family, transcript variant 1 |
FXC02758
|
FHC02758
|
FNC02758N
|
FNC02758C
|
RAB4A |
RAB4A, member RAS oncogene family, transcript variant 1 |
FXC02831
|
FHC02831
|
FNC02831N
|
FNC02831C
|
VPS35 |
VPS35 retromer complex component |
FXC02876
|
FHC02876
|
FNC02876N
|
FNC02876C
|
PTGES2 |
prostaglandin E synthase 2, transcript variant 1 |
FXC02933
|
FHC02933
|
FNC02933N
|
FNC02933C
|
CXCR1 |
chemokine (C-X-C motif) receptor 1 |
FXC03346
|
FHC03346
|
FNC03346N
|
FNC03346C
|
CCR5 |
chemokine (C-C motif) receptor 5 (gene/pseudogene), transcript variant A |
FXC03348
|
FHC03348
|
FNC03348N
|
FNC03348C
|
CXCR2 |
chemokine (C-X-C motif) receptor 2, transcript variant 1 |
FXC03352
|
FHC03352
|
FNC03352N
|
FNC03352C
|
ARFGAP1 |
ADP-ribosylation factor GTPase activating protein 1, transcript variant 1 |
FXC03510
|
FHC03510
|
FNC03510N
|
FNC03510C
|
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 1 |
FXC03635
|
FHC03635
|
FNC03635N
|
FNC03635C
|
RBSN |
rabenosyn, RAB effector, transcript variant 1 |
FXC03746
|
FHC03746
|
FNC03746N
|
FNC03746C
|
RNF41 |
ring finger protein 41, E3 ubiquitin protein ligase, transcript variant 1 |
FXC03829
|
FHC03829
|
FNC03829N
|
FNC03829C
|
ARPC3 |
actin related protein 2/3 complex, subunit 3, 21kDa, transcript variant 1 |
FXC03896
|
FHC03896
|
FNC03896N
|
FNC03896C
|
ARPC2 |
actin related protein 2/3 complex, subunit 2, 34kDa, transcript variant 2 |
FXC04181
|
FHC04181
|
FNC04181N
|
FNC04181C
|
WWP1 |
WW domain containing E3 ubiquitin protein ligase 1 |
FXC04399
|
FHC04399
|
FNC04399N
|
FNC04399C
|
CAV1 |
caveolin 1, caveolae protein, 22kDa, transcript variant 1 |
FXC04442
|
FHC04442
|
FNC04442N
|
FNC04442C
|
CAV2 |
caveolin 2, transcript variant 1 |
FXC04443
|
FHC04443
|
FNC04443N
|
FNC04443C
|
CLTC |
clathrin, heavy chain (Hc), transcript variant 1 |
FXC04587
|
FHC04587
|
FNC04587N
|
FNC04587C
|
IL2RG |
interleukin 2 receptor, gamma |
FXC05514
|
FHC05514
|
FNC05514N
|
FNC05514C
|
PISD |
phosphatidylserine decarboxylase |
FXC06368
|
FHC06368
|
FNC06368N
|
FNC06368C
|
PRKCZ |
protein kinase C, zeta, transcript variant 1 |
FXC06489
|
FHC06489
|
FNC06489N
|
FNC06489C
|
TSG101 |
tumor susceptibility 101 |
FXC07226
|
FHC07226
|
FNC07226N
|
FNC07226C
|
VTA1 |
vesicle (multivesicular body) trafficking 1, transcript variant 1 |
FXC07344
|
FHC07344
|
FNC07344N
|
FNC07344C
|
VPS29 |
VPS29 retromer complex component, transcript variant 1 |
FXC07795
|
FHC07795
|
FNC07795N
|
FNC07795C
|
CHMP2A |
charged multivesicular body protein 2A, transcript variant 2 |
FXC08068
|
FHC08068
|
FNC08068N
|
FNC08068C
|
FOLR1 |
folate receptor 1, transcript variant 2 |
FXC08120
|
FHC08120
|
FNC08120N
|
FNC08120C
|
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila), transcript variant 1 |
FXC08129
|
FHC08129
|
FNC08129N
|
FNC08129C
|
AP2B1 |
adaptor-related protein complex 2, beta 1 subunit, transcript variant 1
|
FXC08267
|
FHC08267
|
|
|
WAS |
Wiskott-Aldrich syndrome |
FXC08646
|
FHC08646
|
FNC08646N
|
FNC08646C
|
RAB11A |
RAB11A, member RAS oncogene family, transcript variant 1 |
FXC08688
|
FHC08688
|
FNC08688N
|
FNC08688C
|
SH3KBP1 |
SH3-domain kinase binding protein 1, transcript variant 1 |
FXC08816
|
FHC08816
|
FNC08816N
|
FNC08816C
|
SNX4 |
sorting nexin 4, transcript variant 1 |
FXC08969
|
FHC08969
|
FNC08969N
|
FNC08969C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
F2R |
coagulation factor II thrombin receptor, transcript variant 1 |
FXC09792
|
FHC09792
|
FNC09792N
|
FNC09792C
|
RAB8A |
RAB8A, member RAS oncogene family |
FXC09821
|
FHC09821
|
FNC09821N
|
FNC09821C
|
STAMBP |
STAM binding protein, transcript variant 1 |
FXC09923
|
FHC09923
|
FNC09923N
|
FNC09923C
|
FGFR4 |
fibroblast growth factor receptor 4, transcript variant 1 |
FXC09979
|
FHC09979
|
FNC09979N
|
FNC09979C
|
RAB35 |
RAB35, member RAS oncogene family, transcript variant 1 |
FXC10060
|
FHC10060
|
FNC10060N
|
FNC10060C
|
CHMP1A |
charged multivesicular body protein 1A, transcript variant 2 |
FXC10411
|
FHC10411
|
FNC10411N
|
FNC10411C
|
FGFR3 |
fibroblast growth factor receptor 3
|
FXC10468
|
FHC10468
|
|
|
FGFR3 |
fibroblast growth factor receptor 3, transcript variant 1 |
FXC10478
|
FHC10478
|
FNC10478N
|
FNC10478C
|
CSF1R |
colony stimulating factor 1 receptor, transcript variant 1 |
FXC10479
|
FHC10479
|
FNC10479N
|
FNC10479C
|
RAB5A |
RAB5A, member RAS oncogene family, transcript variant 1 |
FXC10518
|
FHC10518
|
FNC10518N
|
FNC10518C
|
LDLRAP1 |
low density lipoprotein receptor adaptor protein 1 |
FXC10557
|
FHC10557
|
FNC10557N
|
FNC10557C
|
ARF3 |
ADP-ribosylation factor 3 |
FXC10609
|
FHC10609
|
FNC10609N
|
FNC10609C
|
ARF5 |
ADP-ribosylation factor 5 |
FXC10616
|
FHC10616
|
FNC10616N
|
FNC10616C
|
CCDC53 |
coiled-coil domain containing 53, transcript variant 1
|
FXC10628
|
FHC10628
|
|
|
CLTB |
clathrin, light chain B, transcript variant 2 |
FXC10645
|
FHC10645
|
FNC10645N
|
FNC10645C
|
RAB5C |
RAB5C, member RAS oncogene family, transcript variant 2 |
FXC10658
|
FHC10658
|
FNC10658N
|
FNC10658C
|
CHMP5 |
charged multivesicular body protein 5, transcript variant 1 |
FXC10668
|
FHC10668
|
FNC10668N
|
FNC10668C
|
EHD3 |
EH-domain containing 3 |
FXC10763
|
FHC10763
|
FNC10763N
|
FNC10763C
|
MDM2 |
MDM2 proto-oncogene, E3 ubiquitin protein ligase, transcript variant 1 |
FXC10775
|
FHC10775
|
FNC10775N
|
FNC10775C
|
ARPC5 |
actin related protein 2/3 complex, subunit 5, 16kDa, transcript variant 1 |
FXC10908
|
FHC10908
|
FNC10908N
|
FNC10908C
|
TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
ITCH |
itchy E3 ubiquitin protein ligase, transcript variant 2 |
FXC11019
|
FHC11019
|
FNC11019N
|
FNC11019C
|
IL2RA |
interleukin 2 receptor, alpha, transcript variant 1 |
FXC11183
|
FHC11183
|
FNC11183N
|
FNC11183C
|
CXCR4 |
chemokine (C-X-C motif) receptor 4, transcript variant 1 |
FXC11275
|
FHC11275
|
FNC11275N
|
FNC11275C
|
CDC42 |
cell division cycle 42, transcript variant 2 |
FXC11496
|
FHC11496
|
FNC11496N
|
FNC11496C
|
RAB10 |
RAB10, member RAS oncogene family |
FXC11538
|
FHC11538
|
FNC11538N
|
FNC11538C
|
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant 1 |
FXC11854
|
FHC11854
|
FNC11854N
|
FNC11854C
|
HGS |
hepatocyte growth factor-regulated tyrosine kinase substrate |
FXC11865
|
FHC11865
|
FNC11865N
|
FNC11865C
|
IGF2R |
insulin-like growth factor 2 receptor |
FXC12299
|
FHC12299
|
FNC12299N
|
FNC12299C
|
AMPH |
amphiphysin, transcript variant 1 |
FXC12550
|
FHC12550
|
FNC12550N
|
FNC12550C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
MET |
MET proto-oncogene, receptor tyrosine kinase, transcript variant 2 |
FXC12649
|
FHC12649
|
FNC12649N
|
FNC12649C
|
CBL |
Cbl proto-oncogene, E3 ubiquitin protein ligase |
FXC12662
|
FHC12662
|
FNC12662N
|
FNC12662C
|
PIP5KL1 |
phosphatidylinositol-4-phosphate 5-kinase-like 1, transcript variant 2 |
FXC12666
|
FHC12666
|
FNC12666N
|
FNC12666C
|
PARD3 |
par-3 family cell polarity regulator, transcript variant 2 |
FXC12690
|
FHC12690
|
FNC12690N
|
FNC12690C
|
IST1 |
increased sodium tolerance 1 homolog (yeast), transcript variant 4 |
FXC14621
|
FHC14621
|
FNC14621N
|
FNC14621C
|
VPS45 |
vacuolar protein sorting 45 homolog (S. cerevisiae), transcript variant 1
|
FXC20528
|
FHC20528
|
|
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1, transcript variant 2 |
FXC20642
|
FHC20642
|
FNC20642N
|
FNC20642C
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1, transcript variant 2 |
FXC20644
|
FHC20644
|
|
|
PIKFYVE |
phosphoinositide kinase, FYVE finger containing, transcript variant 2 |
FXC21300
|
FHC21300
|
FNC21300N
|
FNC21300C
|
ERBB4 |
erb-b2 receptor tyrosine kinase 4, transcript variant JM-a/CVT-1 |
FXC21305
|
FHC21305
|
FNC21305N
|
FNC21305C
|
ERBB4 |
erb-b2 receptor tyrosine kinase 4, transcript variant JM-a/CVT-2 |
FXC21306
|
FHC21306
|
FNC21306N
|
FNC21306C
|
CAV3 |
caveolin 3, transcript variant 2 |
FXC21414
|
FHC21414
|
FNC21414N
|
FNC21414C
|
CHMP2B |
charged multivesicular body protein 2B, transcript variant 1 |
FXC21605
|
FHC21605
|
FNC21605N
|
FNC21605C
|
PRKCI |
protein kinase C, iota |
FXC21760
|
FHC21760
|
FNC21760N
|
FNC21760C
|
KDR |
kinase insert domain receptor (a type III receptor tyrosine kinase) |
FXC21921
|
FHC21921
|
FNC21921N
|
FNC21921C
|
ADRB2 |
adrenoceptor beta 2, surface |
FXC22347
|
FHC22347
|
FNC22347N
|
FNC22347C
|
CHMP7 |
charged multivesicular body protein 7 |
FXC23214
|
FHC23214
|
FNC23214N
|
FNC23214C
|
ADRB3 |
adrenoceptor beta 3 |
FXC23242
|
FHC23242
|
FNC23242N
|
FNC23242C
|
STAM |
signal transducing adaptor molecule (SH3 domain and ITAM motif) 1, transcript variant 1 |
FXC23784
|
FHC23784
|
FNC23784N
|
FNC23784C
|
VPS26A |
VPS26 retromer complex component A, transcript variant 1 |
FXC23880
|
FHC23880
|
FNC23880N
|
FNC23880C
|
ADRB1 |
adrenoceptor beta 1 |
FXC24022
|
FHC24022
|
FNC24022N
|
FNC24022C
|
FGFR2 |
fibroblast growth factor receptor 2, transcript variant 1 |
FXC24041
|
FHC24041
|
FNC24041N
|
FNC24041C
|
FGFR2 |
fibroblast growth factor receptor 2, transcript variant 9 |
FXC24045
|
FHC24045
|
|
|
TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
RAB11B |
RAB11B, member RAS oncogene family |
FXC26443
|
FHC26443
|
FNC26443N
|
FNC26443C
|
FBXL15 |
F-box and leucine-rich repeat protein 15 |
FXC27879
|
FHC27879
|
FNC27879N
|
FNC27879C
|
ERBB3 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3, transcript variant 1 |
FXC28149
|
FHC28149
|
FNC28149N
|
FNC28149C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
RAB43 |
RAB43, member RAS oncogene family, transcript variant 1 |
FXC28935
|
FHC28935
|
FNC28935N
|
FNC28935C
|
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit), transcript variant 2 |
FXC01233
|
FHC01233
|
FNC01233N
|
FNC01233C
|
TAP2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP), transcript variant 1, B allele |
FXC01281
|
FHC01281
|
FNC01281N
|
FNC01281C
|
CALR |
calreticulin |
FXC01453
|
FHC01453
|
FNC01453N
|
FNC01453C
|
ITGA5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
FXC01471
|
FHC01471
|
FNC01471N
|
FNC01471C
|
RAB7A |
RAB7A, member RAS oncogene family |
FXC01520
|
FHC01520
|
FNC01520N
|
FNC01520C
|
TFRC |
transferrin receptor, transcript variant 1 |
FXC01759
|
FHC01759
|
FNC01759N
|
FNC01759C
|
THBS1 |
thrombospondin 1 |
FXC01829
|
FHC01829
|
FNC01829N
|
FNC01829C
|
ITGA2 |
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor), transcript variant 1 |
FXC01888
|
FHC01888
|
FNC01888N
|
FNC01888C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
RAB5B |
RAB5B, member RAS oncogene family, transcript variant 1 |
FXC02758
|
FHC02758
|
FNC02758N
|
FNC02758C
|
NCF4 |
neutrophil cytosolic factor 4, 40kDa, transcript variant 1 |
FXC02853
|
FHC02853
|
FNC02853N
|
FNC02853C
|
TUBB |
tubulin, beta class I, transcript variant 2 |
FXC03141
|
FHC03141
|
FNC03141N
|
FNC03141C
|
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12), transcript variant 1A |
FXC03293
|
FHC03293
|
FNC03293N
|
FNC03293C
|
PIK3C3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3, transcript variant 1 |
FXC03294
|
FHC03294
|
FNC03294N
|
FNC03294C
|
M6PR |
mannose-6-phosphate receptor (cation dependent), transcript variant 1 |
FXC03467
|
FHC03467
|
FNC03467N
|
FNC03467C
|
CD209 |
CD209 molecule, transcript variant 1 |
FXC03479
|
FHC03479
|
FNC03479N
|
FNC03479C
|
FCGR1A |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
FXC03501
|
FHC03501
|
FNC03501N
|
FNC03501C
|
CTSS |
cathepsin S, transcript variant 1 |
FXC03574
|
FHC03574
|
FNC03574N
|
FNC03574C
|
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit), transcript variant 1 |
FXC03720
|
FHC03720
|
FNC03720N
|
FNC03720C
|
CORO1A |
coronin, actin binding protein, 1A, transcript variant 2 |
FXC03873
|
FHC03873
|
FNC03873N
|
FNC03873C
|
MBL2 |
mannose-binding lectin (protein C) 2, soluble |
FXC03877
|
FHC03877
|
FNC03877N
|
FNC03877C
|
CD14 |
CD14 molecule, transcript variant 1 |
FXC04493
|
FHC04493
|
FNC04493N
|
FNC04493C
|
CTSL |
cathepsin L, transcript variant 1 |
FXC04676
|
FHC04676
|
FNC04676N
|
FNC04676C
|
ITGAV |
integrin, alpha V, transcript variant 3 |
FXC05547
|
FHC05547
|
FNC05547N
|
FNC05547C
|
STX12 |
syntaxin 12 |
FXC07019
|
FHC07019
|
FNC07019N
|
FNC07019C
|
NCF2 |
neutrophil cytosolic factor 2, transcript variant 1 |
FXC08013
|
FHC08013
|
FNC08013N
|
FNC08013C
|
CYBA |
cytochrome b-245, alpha polypeptide |
FXC08290
|
FHC08290
|
FNC08290N
|
FNC08290C
|
CD36 |
CD36 molecule (thrombospondin receptor), transcript variant 3 |
FXC08370
|
FHC08370
|
FNC08370N
|
FNC08370C
|
TAP1 |
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP), transcript variant 1 |
FXC08722
|
FHC08722
|
FNC08722N
|
FNC08722C
|
FCAR |
Fc fragment of IgA receptor, transcript variant 1 |
FXC09226
|
FHC09226
|
FNC09226N
|
FNC09226C
|
FCGR2B |
Fc fragment of IgG, low affinity IIb, receptor (CD32), transcript variant 1 |
FXC09389
|
FHC09389
|
FNC09389N
|
FNC09389C
|
VAMP3 |
vesicle-associated membrane protein 3 |
FXC09680
|
FHC09680
|
FNC09680N
|
FNC09680C
|
NCF1 |
neutrophil cytosolic factor 1 |
FXC09813
|
FHC09813
|
FNC09813N
|
FNC09813C
|
CANX |
calnexin, transcript variant 1 |
FXC09834
|
FHC09834
|
FNC09834N
|
FNC09834C
|
MARCO |
macrophage receptor with collagenous structure |
FXC10062
|
FHC10062
|
FNC10062N
|
FNC10062C
|
OLR1 |
oxidized low density lipoprotein (lectin-like) receptor 1, transcript variant 1 |
FXC10149
|
FHC10149
|
FNC10149N
|
FNC10149C
|
RILP |
Rab interacting lysosomal protein |
FXC10268
|
FHC10268
|
FNC10268N
|
FNC10268C
|
TLR2 |
toll-like receptor 2 |
FXC10299
|
FHC10299
|
FNC10299N
|
FNC10299C
|
TUBB2A |
tubulin, beta 2A class IIa, transcript variant 1 |
FXC10452
|
FHC10452
|
FNC10452N
|
FNC10452C
|
RAB5A |
RAB5A, member RAS oncogene family, transcript variant 1 |
FXC10518
|
FHC10518
|
FNC10518N
|
FNC10518C
|
FCGR3A |
Fc fragment of IgG, low affinity IIIa, receptor (CD16a), transcript variant 1 |
FXC10547
|
FHC10547
|
FNC10547N
|
FNC10547C
|
SFTPD |
surfactant protein D |
FXC10590
|
FHC10590
|
FNC10590N
|
FNC10590C
|
RAB5C |
RAB5C, member RAS oncogene family, transcript variant 2 |
FXC10658
|
FHC10658
|
FNC10658N
|
FNC10658C
|
ITGB5 |
integrin, beta 5 |
FXC10710
|
FHC10710
|
FNC10710N
|
FNC10710C
|
ITGB3 |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
FXC10787
|
FHC10787
|
FNC10787N
|
FNC10787C
|
C1R |
complement component 1, r subcomponent |
FXC10857
|
FHC10857
|
FNC10857N
|
FNC10857C
|
SEC61G |
Sec61 translocon gamma subunit, transcript variant 2 |
FXC10872
|
FHC10872
|
FNC10872N
|
FNC10872C
|
RAB7B |
RAB7B, member RAS oncogene family, transcript variant 1 |
FXC11097
|
FHC11097
|
FNC11097N
|
FNC11097C
|
SEC61A1 |
Sec61 translocon alpha 1 subunit |
FXC11190
|
FHC11190
|
FNC11190N
|
FNC11190C
|
FCGR2A |
Fc fragment of IgG, low affinity IIa, receptor (CD32), transcript variant 2 |
FXC11459
|
FHC11459
|
FNC11459N
|
FNC11459C
|
HGS |
hepatocyte growth factor-regulated tyrosine kinase substrate |
FXC11865
|
FHC11865
|
FNC11865N
|
FNC11865C
|
SCARB1 |
scavenger receptor class B, member 1 |
FXC12025
|
FHC12025
|
FNC12025N
|
FNC12025C
|
TLR4 |
toll-like receptor 4, transcript variant 1 |
FXC12088
|
FHC12088
|
FNC12088N
|
FNC12088C
|
COLEC11 |
collectin sub-family member 11, transcript variant 1 |
FXC20900
|
FHC20900
|
FNC20900N
|
FNC20900C
|
PIKFYVE |
phosphoinositide kinase, FYVE finger containing, transcript variant 2 |
FXC21300
|
FHC21300
|
FNC21300N
|
FNC21300C
|
TLR6 |
toll-like receptor 6 |
FXC21893
|
FHC21893
|
FNC21893N
|
FNC21893C
|
MSR1 |
macrophage scavenger receptor 1, transcript variant SR-AI |
FXC23196
|
FHC23196
|
FNC23196N
|
FNC23196C
|
NANOS1 |
nanos homolog 1 (Drosophila) |
FXC24034
|
FHC24034
|
FNC24034N
|
FNC24034C
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
C3 |
complement component 3 |
FXC31634
|
FHC31634
|
FNC31634N
|
FNC31634C
|
NOS1 |
nitric oxide synthase 1 (neuronal), transcript variant 1
|
FXC31690
|
FHC31690
|
|
|
RB1CC1 |
RB1-inducible coiled-coil 1, transcript variant 1 |
FXC00035
|
FHC00035
|
FNC00035N
|
FNC00035C
|
ATG13 |
autophagy related 13, transcript variant 1 |
FXC00591
|
FHC00591
|
FNC00591N
|
FNC00591C
|
ATG14 |
autophagy related 14
|
FXC00648
|
FHC00648
|
|
|
PIK3R4 |
phosphoinositide-3-kinase, regulatory subunit 4 |
FXC01201
|
FHC01201
|
FNC01201N
|
FNC01201C
|
PIK3C3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3, transcript variant 1 |
FXC03294
|
FHC03294
|
FNC03294N
|
FNC03294C
|
ATG14 |
autophagy related 14 |
FXC07587
|
FHC07587
|
FNC07587N
|
FNC07587C
|
INS |
insulin, transcript variant 1 |
FXC08231
|
FHC08231
|
FNC08231N
|
FNC08231C
|
BECN1 |
beclin 1, autophagy related |
FXC08488
|
FHC08488
|
FNC08488N
|
FNC08488C
|
ATG3 |
autophagy related 3, transcript variant 1 |
FXC09135
|
FHC09135
|
FNC09135N
|
FNC09135C
|
ATG10 |
autophagy related 10, transcript variant 2 |
FXC10847
|
FHC10847
|
FNC10847N
|
FNC10847C
|
ATG16L1 |
autophagy related 16-like 1, transcript variant 1 |
FXC10859
|
FHC10859
|
FNC10859N
|
FNC10859C
|
GABARAP |
GABA(A) receptor-associated protein |
FXC12545
|
FHC12545
|
FNC12545N
|
FNC12545C
|
PRKAA2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
FXC20333
|
FHC20333
|
FNC20333N
|
FNC20333C
|
ATG12 |
autophagy related 12 |
FXC22258
|
FHC22258
|
FNC22258N
|
FNC22258C
|
ATG5 |
autophagy related 5, transcript variant 1 |
FXC22710
|
FHC22710
|
FNC22710N
|
FNC22710C
|
IFNA17 |
interferon, alpha 17 |
FXC23478
|
FHC23478
|
FNC23478N
|
FNC23478C
|
IFNA2 |
interferon, alpha 2 |
FXC23482
|
FHC23482
|
FNC23482N
|
FNC23482C
|
IFNG |
interferon, gamma |
FXC24802
|
FHC24802
|
FNC24802N
|
FNC24802C
|